175 related articles for article (PubMed ID: 20570808)
1. Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review.
Mansoori LS; Catel CP; Rothman MS
Endocr Pract; 2010; 16(5):851-4. PubMed ID: 20570808
[TBL] [Abstract][Full Text] [Related]
2. Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction.
Wu D; Ma J; Bao S; Guan H
Rheumatol Int; 2015 Apr; 35(4):767-72. PubMed ID: 25230905
[TBL] [Abstract][Full Text] [Related]
3. An extensive hemimelic polyostotic fibrous dysplasia: a case report.
Mrabet D; Rekik S; Sahli H; Ben Amor M; Meddeb N; Sellami S
Rheumatol Int; 2012 Apr; 32(4):1075-8. PubMed ID: 21331571
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial fibrous dysplasia: A 10-case series.
Couturier A; Aumaître O; Gilain L; Jean B; Mom T; André M
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):229-235. PubMed ID: 28302454
[TBL] [Abstract][Full Text] [Related]
5. Giant Hemifacial Fibrous Dysplasia Functional Treatment and Place of Pamidronate.
Bachelet JT; Mendes LC; Delafond C; Barba T; Gleizal A; Paulus C
J Craniofac Surg; 2017 May; 28(3):706-708. PubMed ID: 28468152
[TBL] [Abstract][Full Text] [Related]
6. [Fibrous dysplasia: differential diagnosis from Paget's disease].
Wagner P; Heilmann P; Schulz A; Nawroth P; Kasperk Ch
Dtsch Med Wochenschr; 2002 Oct; 127(43):2264-8. PubMed ID: 12397541
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood.
Chan B; Zacharin M
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):75-80. PubMed ID: 16509531
[TBL] [Abstract][Full Text] [Related]
8. Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia.
Rastogi A; Bhadada SK; Bhansali A
Indian J Pediatr; 2012 May; 79(5):667-9. PubMed ID: 21761121
[TBL] [Abstract][Full Text] [Related]
9. [Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome].
Pfeilschifter J; Ziegler R
Med Klin (Munich); 1998 Jun; 93(6):352-9. PubMed ID: 9662942
[TBL] [Abstract][Full Text] [Related]
10. Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience.
Valadares LP; de Araújo Ferreira BS; da Cunha BM; Moreira LA; Batista FGA; da Fonseca Hottz C; Magalhães GGR
Arch Endocrinol Metab; 2022 Apr; 66(2):247-255. PubMed ID: 35420267
[TBL] [Abstract][Full Text] [Related]
11. Therapy with zoledronic acid, 5 mg, for a patient with Paget disease of bone.
Tucci JR
Endocr Pract; 2008; 14(5):607-10. PubMed ID: 18753106
[TBL] [Abstract][Full Text] [Related]
12. [Fibrous dysplasia of bone in a 12-year old girl].
Bieniasz J; Maj A; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):69-72. PubMed ID: 16704865
[TBL] [Abstract][Full Text] [Related]
13. Unilateral exophthalmos associated with severe fibrous dysplasia.
Kuhli C; Luchtenberg M; Weidauer S; Ohrloff C
Ophthalmologica; 2005; 219(3):181-4. PubMed ID: 15947505
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate therapy for fibrous dysplasia.
DiMeglio LA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome.
Lala R; Matarazzo P; Bertelloni S; Buzi F; Rigon F; de Sanctis C
Acta Paediatr; 2000 Feb; 89(2):188-93. PubMed ID: 10709889
[TBL] [Abstract][Full Text] [Related]
16. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.
Plotkin H; Rauch F; Zeitlin L; Munns C; Travers R; Glorieux FH
J Clin Endocrinol Metab; 2003 Oct; 88(10):4569-75. PubMed ID: 14557424
[TBL] [Abstract][Full Text] [Related]
17. An extensive type of polyostotic fibrous dysplasia.
Sener RN
Pediatr Radiol; 1997 Apr; 27(4):339-41. PubMed ID: 9094244
[TBL] [Abstract][Full Text] [Related]
18. EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE.
Wang Y; Wang O; Jiang Y; Li M; Xia W; Meng X; Xing X
Endocr Pract; 2019 Jan; 25(1):23-30. PubMed ID: 30383490
[TBL] [Abstract][Full Text] [Related]
19. [A case of polyostotic fibrous dysplasia].
Klempous J; Kuźniar J; Sztuka A; Jaworska M
Wiad Lek; 2006; 59(1-2):125-7. PubMed ID: 16646308
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.
Lala R; Matarazzo P; Andreo M; Marzari D; Bellone J; Corrias A; de Sanctis C;
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():583-93. PubMed ID: 16789621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
